The Ensign Group operates skilled nursing, senior living and other post-acute care facilities across multiple U.S. states. It is known for a highly decentralized model in which local leaders run individual facilities with significant operational autonomy. Growth has often come from acquiring underperforming properties and improving clinical and financial results under that local-empowerment approach.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q1 2025 | 1,173 | — | 80.3 | 9% |
| Q2 2025 | 1,227.8 | — | 84.4 | 12.3% |
| Q3 2025 | 1,296.4 | — | 83.8 | 5.6% |
| Q4 2025 | 1,360.6 | — | 95.5 | 11.8% |
| Q1 2026 | 1,389.2 | 18.4% | 99.7 | 24.2% |
| Q2 2026 | 1,440.5 | 17.3% | 99.7 | 18.2% |
All markets — KeepWinning global stock screener
Other companies on Nasdaq: Ionis Pharmaceuticals, Inc. (IONS), Henry Schein, Inc. (HSIC), Cytokinetics, Incorporated (CYTK), Lineage, Inc. (LINE), Old National Bancorp (ONB), Praxis Precision Medicines, Inc. (PRAX)